Taxol®
Company
Bristol-Myers Squibb Company
Use
Treatment of advanced carcinoma of the ovary and as adjuvant treatment of node-positive breast cancer
Features
Extensive clinical development was done by NCI
NIH Contribution
Improved the method for administering paclitaxel
Approval Type
FDA
HHS Institute/Agency
NCI
Inventor(s)
G. Vande Woude, W. Wilson, and E. Reed
Year
1992
Tech Cat
Therapeutic
